#
Hyaluronidase and trastuzumab
  • Treatments
  • Breast Cancer

Hyaluronidase and trastuzumab

Generic name: hyaluronidase and trastuzumab [ HYE-al-ure-ON-i-dase-and-tras-TOO-zoo-mab ]
Brand name: Herceptin Hylecta
Dosage form: subcutaneous solution (10,000 units-600 mg/5 mL)
Drug class:HER2 inhibitors

Medically reviewed by Drugs.com on Apr 5, 2022. Written by Cerner Multum.

What is hyaluronidase and trastuzumab?

Hyaluronidase is a genetically designed protein. Trastuzumab is a cancer medicine.

Hyaluronidase and trastuzumab is a combination medicine used to treat certain types of breast cancer.

Hyaluronidase and trastuzumab may also be used for purposes not listed in this medication guide.

Warnings

hyaluronidase and trastuzumab can cause heart failure, especially if you have heart disease or if you are also receiving certain other cancer medicines.

Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, nauseated, feverish, chilled, short of breath, or if you have diarrhea, a rash, chest pain, swelling in your face, or trouble breathing.

Before taking this medicine

This medicine can cause heart failure, especially if you have heart disease or if you are also receiving certain other cancer medicines (such as daunorubicin, doxorubicin, epirubicin, or idarubicin)

Tell your doctor if you have ever had:

Do not use hyaluronidase and trastuzumab if you are pregnant. This medicine can cause injury or death to the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 7 months after your last dose.

If you become pregnant while using this medicine or within 7 months after you stop, your name may be listed on a pregnancy registry to track the effects of hyaluronidase and trastuzumab on the baby.

It may not be safe to breast-feed while using this medicine and for up to 7 months after your last dose. Ask your doctor about any risk.

How is hyaluronidase and trastuzumab given?

hyaluronidase and trastuzumab is injected under the skin, usually once every 3 weeks.

A healthcare provider will give you this injection.

Hyaluronidase and trastuzumab is usually given for 1 year, or until your body no longer responds to the medicine.

You may need frequent medical tests to be sure this medicine is not causing harmful e...